Radio and PodcastLive Radio & Podcasts
Science & Medicine
Experimental Compounds Push Cancer-Promoting Pathways Into Overdrive in Pancreatic Cancer Cells
Pancreatic cancer remains one of the most difficult cancers to treat, in part because mutations in the KRAS gene are extraordinarily common in pancreatic ductal adenocarcinoma (PDAC). These mutations keep growth-promotin...
Related Episodes
Continue listening to more episodes from Oncotarget.
Tumor-Infiltrating Lymphocyte Therapy Offers a Promising Approach for Treating Solid Tumors
Aug 31, 2026 - 00:04:20
KRAS G12C Mutation Identified as a Rare Potential Target in Genitourinary Cancers
Aug 28, 2026 - 00:04:29
New Analysis Challenges Methods Used to Measure Residual DNA in mRNA Vaccines
Aug 25, 2026 - 00:06:37
Trk and IGF1R-Related Signaling Linked to Delayed Ewing Sarcoma Growth
Aug 10, 2026 - 00:06:50
CTHRC1 in the Tumor Microenvironment Drives Colorectal Cancer Growth in Mouse Study
Aug 10, 2026 - 00:09:03
Artificial Intelligence Could Transform Nutrition Care for Cancer Patients
Jul 28, 2026 - 00:08:41
